S100A9 and chronic obstructive pulmonary disease: S100A9 mediates a variety of respiratory diseases, such as chronic obstructive pulmonary disorder (COPD) and infectious diseases, including tuberculosis, influenza and coronavirus disease 2019 (COVID-19) by forming a heterodimer with S100A8 (Mellett and Khader 2022).